Curbing the price of novel diabetes and obesity medications

Medical Xpress

Center

High Factuality

Curbing the price of novel diabetes and obesity medications

For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been advocating for affordable pricing of insulin, an essential —and sometimes lifesaving—drug for many individuals with diabetes. Now, she is turning her attention to a similar trend of soaring prices among new diabetes and obesity medications.